Autopsy report · NCT03286582

A Proof-of-Concept Study of Topical AC-203 in Patients With Bullous Pemphigoid

“Terminated with partial enrollment completed”

The sponsor’s own words in the registry.

Life of this trial

• Ran for about 1 year 5 months before it stopped.
• 10 participants enrolled.
• No results are posted on the registry.

Vital statistics

Status

Terminated

Phase

Phase 2

Sponsor

TWi Biotechnology, Inc.

Sponsor type

Industry

Conditions

Bullous Pemphigoid

Interventions

AC-203 1% Topical Ointment; Clobetasol 0.05% Topical Ointment

Participants

10

Sites

1

Countries

Taiwan

Look deeper

• The official registry record (the source of truth)
• Record history: every change the sponsor made
• Open it in the database

Everything here comes from the current ClinicalTrials.gov record. The timeline uses the record’s dates; dates marked planned are the sponsor’s plans. The cause of death is an automatic, unverified label. This is research information, not medical advice.